Abstract
Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Current Alzheimer Research
Title: Risk Factors of Alzheimers Disease Among Iranian Population
Volume: 5 Issue: 1
Author(s): Mahshid Foroughan, Zia Ghaemmagham Farahani, Maryam Shariatpanahi, Mehrak Vaezinejad, Ahmad Ali Akbari Kamerani and Mehrdad Sheikhvatan
Affiliation:
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Abstract: Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Export Options
About this article
Cite this article as:
Foroughan Mahshid, Farahani Ghaemmagham Zia, Shariatpanahi Maryam, Vaezinejad Mehrak, Akbari Kamerani Ali Ahmad and Sheikhvatan Mehrdad, Risk Factors of Alzheimers Disease Among Iranian Population, Current Alzheimer Research 2008; 5 (1) . https://dx.doi.org/10.2174/156720508783884594
DOI https://dx.doi.org/10.2174/156720508783884594 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research A Systematic Review of Overweight, Obesity, and Type 2 Diabetes Among Asian American Subgroups
Current Diabetes Reviews Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Structure-Based Discovery of PDEs Inhibitors
Current Topics in Medicinal Chemistry Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan
Current Drug Delivery Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis
CNS & Neurological Disorders - Drug Targets The Burden of Metabolic Diseases Amongst HIV Positive Patients on HAART Attending the Johannesburg Hospital
Current HIV Research Recent Updates on the Association Between Alzheimer’s Disease and Vascular Dementia
Medicinal Chemistry Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery Polyphenols: Novel Signaling Pathways
Current Pharmaceutical Design Mouse Models and the Role of Nitric Oxide in Reproduction
Current Pharmaceutical Design Dissecting the Mechanisms of Thrombogenesis and Atherosclerosis for Neurodegenerative Disorders
Current Neurovascular Research On the Cellular and Molecular Regulatory Transcriptional Mechanisms and Responsive Putative Pathways to Inflammatory Oxidative Stress Revisited: Current Immunological Breakthroughs and Views at a Glance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hydroxyimine NO-Donors; FK409 and Derivatives
Current Topics in Medicinal Chemistry Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions
Current Clinical Pharmacology Beyond Mitochondria, What Would be the Energy Source of the Cell?
Central Nervous System Agents in Medicinal Chemistry Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets Pharmacotherapy of Obesity - Benefit, Bias and Hyperbole
Current Medicinal Chemistry Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology